Iovance Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
Comprehensive ESG assessment of Iovance Biotherapeutics Inc can be reached by logging in. This Disclosure score includes seventeen United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. Other corporations in the scoring industry group for Iovance Biotherapeutics Inc are displayed below.
Iovance Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 3.4, social score of 3.0 and governance score of 6.0.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1252 | Wntresearch AB | 4.5 | High |
| 1252 | Verano Holdings Corp | 4.5 | High |
| 1284 | Iovance Biotherapeutics Inc | 4.4 | High |
| 1284 | Adinath Biolabs Ltd | 4.4 | High |
| 1284 | Aligos Therapeutics Inc | 4.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Iovance Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Iovance Biotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Iovance Biotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Iovance Biotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Iovance Biotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Iovance Biotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Iovance Biotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Iovance Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.